UNOS分析:柏林心脏桥接移植在获得性与先天性心脏病中的比较
基于UNOS数据库806例<18岁使用柏林心脏VAD桥接心脏移植的患者,比较获得性心脏病(AHD,n=573)与先天性心脏病(CHD,n=233)的移植后生存。CHD组5年移植后生存率74.3%(95%CI 67.5%-81.7%)低于AHD组85.8%(95%CI 82.5%-89.2%);但移植后存活1年的患者两组后续生存无显著差异。多变量分析显示CHD诊断与死亡风险增加显著相关(HR 1.645;95%CI 1.075-2.487;
要点
- CHD组5年移植后生存率74.3%,低于AHD组的85.8%。
- 移植后存活1年的患者,两组2至5年生存无显著差异。
- 多变量分析中CHD诊断与死亡风险增加显著相关(HR 1.645)。
核心结论
- 控制人口学差异和移植前危险因素后,使用柏林心脏VAD桥接移植的CHD患者长期生存劣于AHD患者。
研究设计与样本
- 回顾性队列研究,查询UNOS数据库,纳入美国<18岁接受心脏移植且术前使用柏林心脏VAD支持的806例患者(AHD n=573,CHD n=233),按诊断分层,行单变量和多变量分析评估基线特征和移植后生存。
主要发现
- CHD组估计5年移植后生存率74.3%(95%CI 67.5%-81.7%),低于AHD组的85.8%(95%CI 82.5%-89.2%)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study evaluated long-term survival in pediatric patients who were bridged to transplantation with the Berlin Heart ventricular assist device by comparing patients with congenital heart disease (CHD) with patients with acquired heart disease (AHD). METHODS: The United Network for Organ Sharing Database was queried for patients (aged <18 years) who received a heart transplant in the United States and were preoperatively supported with the Berlin Heart ventricular assist device. Patients were stratified by a diagnosis of AHD vs CHD. Univariable and multivariable analyses were performed to assess baseline characteristics and posttransplant survival. RESULTS: This cohort included 806 patients (n = 573 AHD, n = 233 CHD). Patients with CHD and AHD were of similar size (weight [kg], 12.8 ± 9.27 vs 15.3 ± 13.6; P = .107), and most were aged <1 year (34.9%; n = 281) or 1 to 5 years (45.3%; n = 365). Ventricular assist device configuration differed between patients with CHD and AHD: 70.4% (n = 164) vs 75% (n = 430) were supported with a left ventricular assist device, 9.9% (n = 23) vs 0.7% (n = 4) were supported with a right ventricular assist device, and 19.7% (n = 46) vs 24.3% (n = 139) were supported with a biventricular assist device (P < .001). Patients with CHD were more often male (57.1% [n = 133] vs 46.9% [n = 269]; P = .011), and they had worse estimated 5-year posttransplant survival at 74.3% (95% CI, 67.5%-81.7%) compared with 85.8% (95% CI, 82.5%-89.2%) in patients with AHD. However, for patients who survived the first year after transplantation, posttransplantation survival was similar between the groups (P > .05 at 2, 3, 4, and 5-years). In multivariable analysis, a CHD diagnosis was significantly associated with an increased risk for mortality (hazard ratio, 1.645; 95% CI, 1.075-2.487; P = .021). CONCLUSIONS: After controlling for demographic variations and pretransplant risk factors, patients with CHD who were bridged to transplant with the Berlin Heart ventricular assist device had worse long-term survival than patients with AHD who were bridged to transplant with the Berlin Heart ventricular assist device.
引用
- Bilgili A, Sharaf OM, Verzwyvelt Z, et al. Analysis of UNOS: Berlin Heart Bridge to Transplant in Acquired vs Congenital Heart Disease. Ann Thorac Surg. 2024. PMID: 39326523. doi:10.1016/j.athoracsur.2024.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。